HomeVRCA • NASDAQ
add
Verrica Pharmaceuticals Inc
Previous close
$6.85
Day range
$6.65 - $6.86
Year range
$2.86 - $7.76
Market cap
288.02M USD
Avg Volume
161.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.99M | 2,823.53% |
Operating expense | 19.58M | 321.06% |
Net income | -24.61M | -314.94% |
Net profit margin | -1.24K | 85.81% |
Earnings per share | -0.53 | -278.57% |
EBITDA | -20.45M | -236.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 69.55M | 102.92% |
Total assets | 81.60M | 82.46% |
Total liabilities | 61.83M | 1,218.98% |
Total equity | 19.76M | — |
Shares outstanding | 42.42M | — |
Price to book | 14.57 | — |
Return on assets | -57.62% | — |
Return on capital | -68.03% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -24.61M | -314.94% |
Cash from operations | -14.51M | -192.83% |
Cash from investing | -227.00K | -103.36% |
Cash from financing | -27.00K | — |
Net change in cash | -14.76M | -920.06% |
Free cash flow | -7.52M | -142.40% |
About
CEO
Founded
2013
Headquarters
Website
Employees
100